Sélectionner la langue 
English (United States) 
English (Other Regions) 
French 
German 
Italian 
Japanese 
Russian 
Spanish 
Chinese 
VASCADE MVP®
Simple. Safer. Faster. (a)
VASCADE MVP® venous vascular closure system provides rapid haemostasis for electrophysiology (EP) procedures, enabling patients to get back on their feet faster.(1) The VASCADE MVP system is simple and easy-to-use for a fast-learning curve. It has demonstrated 0% major complications (b) in 1,223 patients in 5 EP clinical trials.(1-5)
In the AMBULATE Randomised Controlled Trial (RCT), the VASCADE MVP system has proven a time to ambulation after 2.2h, which is faster compared to manual compression.(1) The benefits of early ambulation are less pain, less pain medication use and an increase in patient satisfaction.(1) The VASCADE MVP system supports procedural efficiency and is therefore ideal for Same Day Discharge.(1-5)
The VASCADE MVP system is indicated for use in multi-stick and multi-limb catheter-based procedures.(6) It leaves no permanent materials in the body, due to the fully resorbable, extravascular collagen patch.
(a) Compared to manual compression.
(b) Major venous access site closure-related complications through the follow-up period.
VASCADE MVP® System
Make a selection to learn more
VASCADE MVP® System
A Simple Design for a Fast Learning Curve
Ordering Information
|
AMBULATE Trial
The VASCADE MVP® system is indicated for use in catheter-based procedures with single or multiple access sites in one or both limbs.6 It is an extravascular closure device to offer collagen with a dual method of action, mechanical and physiological. The bioabsorbable thrombogenic collagen patch expands by 13X to fill the tissue tract.7 As it is extravascular and the collagen patch resorbs; it leaves no sutures or other materials behind in the vessel. Therefore, the VASCADE MVP system allows for re-access, after 30 days, for repeat ablation procedures.
The VASCADE MVP system is simple and easy-to-use and allows haemostasias to be achieved in 3 simple steps.
Safer Procedure, Safer for the Patient1-5,a
Ordering Information
|
AMBULATE Trial
The AMBULATE clinical studies have demonstrated 0% major complications8 in 1,223 total patients studied in 5 EP clinical trials, including 4 trials studying same-day discharge paroxysmal and persistent AF ablation patients.1-5
The AMBULATE randomised clinical trial, comparing the VASCADE MVP® system to manual compression, has demonstrated 0% major complications and a significantly lower rate of minor complications.
The device success was 97% and procedure success was 98%.
a. Compared to manual compression
Fast Patient Ambulation1,a
Ordering Information
|
AMBULATE Trial
|
Same Day Discharge
The AMBULATE RCT has shown that the use of the VASCADE MVP® system reduces the time to ambulation compared to manual compression. It was demonstrated that the median time to ambulation was 2.2 hours, which results in a 64% reduction in median time to ambulation compared to manual compression.1
The RCT confirmed a 63% improvement in patient satisfaction. This might be driven by the 25% reduction of pain and a 51% reduction in pain medication use post-procedure/following ablation.1
Simple and Easy to Use
✓ Single operator
✓ Indicated
• For use in 6F to 12F ID (max 15F OD) 12 cm introducer sheathsa
• For single or multiple access sites in one or both limbs
✓ 2 mechanisms of action
• Mechanical
• Physiological
✓ Extravascular design
• No permanent or intraluminal implants
• No sutures or material left in vessel
✓ Bioabsorbable and thrombogenic collagen patch
• Expands to fill tissue tract
aOverall length of the sheath (including the hub) needs to be less than 15 cm
Resource Centre
Find the information you need as you browse through helpful, on-demand information to aid in your understanding of our vascular closure solutions.
Featured Resources View all resources
Instructions for Use
The VASCADE MVP® Venous Vascular Closure System (VVCS) is intended to seal the femoral venous access site(s) by delivering a resorbable collagen patch, extra-vascularly, at the vessel puncture site to aid in achieving haemostasis.
VASCADE MVP® Brochure
The VASCADE MVP system provides rapid haemostasis for electrophysiology procedures, enabling patients to get up and moving earlier.
AMBULATE Trial
This prospective, multicentre, randomised study compared the efficacy and safety of the VASCADE MVP® system to manual compression for closing multiple access sites after catheter-based EP procedures.
AMBULATE Same Day Discharge Clinical Studies
This prospective, multicentre single arm registry evaluates procedural outcomes using the VASCADE MVP® system following atrial fibrillation interventions for patients who are discharged the same day.
Ordering Information
| Catalogue Number | Description | Order Quantity |
| 800-612C-10E | 6-12 French (Inner Diameter) | 1 Box (10 devices per box) |
| Catalogue Number | Description | Order Quantity |
| 700-500DX-05E | 5 French (Inner Diameter) | 1 Box (5 devices per box) |
| Catalogue Number | Description | Order Quantity |
| 700-580I-05E | 6/7 French (Inner Diameter) | 1 Box (5 devices per box) |
2. Al-Ahmad A, et al. Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the mid-bore venous vascular closure system. VASCADE MVP following multi-access cardiac ablation procedures. J Cardiovasc Electrophysiol 2021. 32(2): 191-99.
3. AMBULATE Same Day Discharge Registry Retrospective Study: NCT04538781.
4/5. Eldadah ZA, et al. Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A post-market registry. J Cardiovasc Electrophysiol 2022. https://doi. org/10.1111/jce.15763. NCT04203329.
6. Catheter-based cardiac ablations requiring two or more venous access sites within the same limb. See VASCADE MVP IFU 5686 Indications for Use.
7. Data on file at Haemonetics.
8. Major venous access site closure-related complications through the follow up.
.jpg?la=en-gb&hash=C68011FE67002CA9B3D5CEF033EFE284)
Communiquez avec nous
Les produits ne sont pas tous disponibles dans tous les marchés.